Published in Lab Law Weekly, March 2nd, 2007
The alliance, among other things, involves consideration to TyRx Pharma for the licensing of certain TyRx technologies and proprietary know-how and co-development with a Bard subsidiary utilizing TyRx technology and manufacturing know-how with certain products of a Bard subsidiary. Terms were not announced.
The law firm of McDermott Will & Emery LLP represented TyRx Pharma in the transaction.
On December 6, TyRx was awarded ISO 9001:2000...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.